UWP
HUMA icon

Uniting Wealth Partners’s Humacyte HUMA Stock Holding History

Uniting Wealth Partners’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2K Sell
15,609
-1,000
-6% -$927 ﹤0.01% 207
2026
Q1 		$10.1K Hold
16,609
– – ﹤0.01% 205
2025
Q4 		$16K Hold
16,609
– – ﹤0.01% 152
2025
Q3 		$28.9K Sell
16,609
-22,675
-58% -$44.4K 0.01% 196
2025
Q2 		$82.1K Sell
39,284
-700
-2% -$1.34K 0.03% 114
2025
Q1 		$68.2K Buy
39,984
+430
+1% +$1.61K 0.03% 105
2024
Q4 		$200K Buy
+39,554
New +$196K 0.1% 97

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Uniting Wealth Partners's HUMA Position: Q2 2026 in Review

Uniting Wealth Partners reduced its Humacyte (HUMA) stake by 6% in Q2 2026, selling an estimated $927 and leaving 15,609 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #207.

Uniting Wealth Partners first reported a position in HUMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $200K in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Uniting Wealth Partners held 15,609 shares of Humacyte worth $12.2K as of Q2 2026.
  • Uniting Wealth Partners sold 1,000 Humacyte shares in Q2 2026, an estimated $927.
  • Humacyte made up ﹤0.01% of Uniting Wealth Partners's portfolio in Q2 2026, its #207 holding.
  • Uniting Wealth Partners first reported a position in Humacyte in Q4 2024 and has held it in 7 quarters since.
  • Uniting Wealth Partners's Humacyte position peaked at $200K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Uniting Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.